Share this page

Recommended reading

Homburg R, Hendriks ML, König TE, Anderson RA, Balen AH, Brincat M, Child T, Davies M, D'Hooghe T, Martinez A, Rajkhowa M, Rueda-Saenz R, Hompes P, Lambalk CB. Clomifene citrate or low-dose FSH for the first-line treatment of infertile women with anovulation associated with polycystic ovary syndrome: a prospective randomized multinational study. Hum Reprod. 2012 Feb;27(2):468-73

 

Broer S, Eijkemans MJ, Scheffer GJ, van Rooij IA, de Vet A, Themmen AP, Laven JS, de Jong FH, Te Velde ER, Fauser BC, Broekmans FJ. Anti-Mullerian hormone predicts menopause: a long term follow-up study in normoovulatory women. Journal of Clinical Endocrinology and Metabolism 2011 Aug;96(8):2532-9

 

An indispensible help for every practicing gynecological endocrinologist – from novice to expert - is the WHO document “Medical eligibility criteria for contraceptive use”. This document reviews the medical eligibility criteria for use of contraception, offering guidance on the safety of use of different methods for women and men with specific characteristics or known medical conditions. The recommendations are based on systematic reviews of available clinical and epidemiological research.